High activity and tolerability demonstrated for exemestane in postmenopausal women with metastatic breast cancer who had previously failed on tamoxifen treatment. | Eur J Cancer;36(8): 976-82, 2000 May. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

High activity and tolerability demonstrated for exemestane in postmenopausal women with metastatic breast cancer who had previously failed on tamoxifen treatment.

Kvinnsland, S; Anker, G; Dirix, L Y; Bonneterre, J; Prove, A M; Wilking, N; Lobelle, J P; Mariani, O; di Salle, E; Polli, A; Massimini, G.

Affiliation

Kvinnsland S; Radiumhospital, Oslo, Norway.

Eur J Cancer ; 36(8): 976-82, 2000 May.

Article in En | MEDLINE | ID: mdl-10885600

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms / Antineoplastic Agents, Hormonal / Enzyme Inhibitors / Androstadienes Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Eur J Cancer Year: 2000 Document type: Article Affiliation country:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms / Antineoplastic Agents, Hormonal / Enzyme Inhibitors / Androstadienes Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Eur J Cancer Year: 2000 Document type: Article Affiliation country: